Symptom Burden, Survival and Palliative Care in Advanced Soft Tissue Sarcoma

Table 2

All documented symptoms prior to different palliative treatment decisions. (Due to the small numbers, only documented symptoms at the time of first- and second-line chemotherapy and best supportive care decision are displayed).

Symptom	First-line palliative chemotherapy; (𝑛=50)	Second-line palliative chemotherapy; (𝑛=28)	Best supportive care; (𝑛=48)
	Symptom prevalence	Symptom prevalence	Symptom prevalence
Pain	25 (50%)	23 (82%)	38 (79%)
Breathlessness	10 (20%)	11 (40%)	21 (44%)
Nausea and vomiting	11 (22%)	5 (18%)	17 (35%)
Fatigue	9 (18%)	5 (18%)	16 (33%)
Constipation	6 (12%)	2 (7%)	8 (17%)
Cough	3 (6%)	3 (11%)	9 (19%)
Feeling bloated	9 (18%)	2 (7%)	3 (6%)
Weight loss	6 (12%)	0 (0%)	1 (2%)
Low appetite	4 (8%)	0 (0%)	9 (19%)
Diarrhoea	1 (2%)	0 (0%)	4 (8%)
Dry mouth	1 (2%)	1 (4%)	3 (6%)
Trouble sleeping	2 (4%)	0 (0%)	4 (8%)
Numbness/tingling in hands/feet	0 (0%)	1 (4%)	3 (6%)
Problems with urination	2 (4%)	0 (0%)	2 (4%)
Sweats	0 (0%)	0 (0%)	1 (2%)